BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37084595)

  • 1. Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones.
    Fedorowicz J; Cruz CD; Morawska M; Ciura K; Gilbert-Girard S; Mazur L; Mäkkylä H; Ilina P; Savijoki K; Fallarero A; Tammela P; Sączewski J
    Eur J Med Chem; 2023 Jun; 254():115373. PubMed ID: 37084595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
    Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
    Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents.
    Fedorowicz J; Sączewski J; Konopacka A; Waleron K; Lejnowski D; Ciura K; Tomašič T; Skok Ž; Savijoki K; Morawska M; Gilbert-Girard S; Fallarero A
    Eur J Med Chem; 2019 Oct; 179():576-590. PubMed ID: 31279292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
    Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH
    Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-substituted piperazinyl sarafloxacin derivatives: synthesis and in vitro antibacterial evaluation.
    Asadipour A; Moshafi MH; Khosravani L; Moghimi S; Amou E; Firoozpour L; Ilbeigi G; Beiki K; Soleimani E; Foroumadi A
    Daru; 2018 Dec; 26(2):199-207. PubMed ID: 30392156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A; Joseph J; Sharma S; Nutheti R; Garg P; Das T
    Indian J Ophthalmol; 2007; 55(1):15-9. PubMed ID: 17189881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives. Versatile in vitro biological evaluations of monomeric and dimeric fluoroquinolone derivatives as potential antitumor, antibacterial or antimycobacterial agents.
    Azéma J; Guidetti B; Korolyov A; Kiss R; Roques C; Constant P; Daffé M; Malet-Martino M
    Eur J Med Chem; 2011 Dec; 46(12):6025-38. PubMed ID: 22036229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terpene-Functionalized Fluoroquinolones as Potential Antimicrobials: Synthesis and Properties.
    Izmest'ev ES; Pestova SV; Kolesnikova AI; Baidamshina DR; Kayumov AR; Rubtsova SA
    ChemMedChem; 2023 Dec; 18(24):e202300358. PubMed ID: 37872856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens.
    Kazamori D; Aoi H; Sugimoto K; Ueshima T; Amano H; Itoh K; Kuramoto Y; Yazaki A
    Int J Antimicrob Agents; 2014 Nov; 44(5):443-9. PubMed ID: 25239276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study.
    Abdel-Aziz AA; Asiri YA; Al-Agamy MH
    Eur J Med Chem; 2011 Nov; 46(11):5487-97. PubMed ID: 21982337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus.
    Samir M; Ramadan M; Abdelrahman MH; Elbastawesy MAI; Halby HM; Abdel-Aziz M; Abuo-Rahma GEA
    Bioorg Med Chem; 2022 Nov; 73():117004. PubMed ID: 36148773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.
    Otani T; Tanaka M; Ito E; Kurosaka Y; Murakami Y; Onodera K; Akasaka T; Sato K
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3750-9. PubMed ID: 14638477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
    Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL
    Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity and action mode of Cu(I) and Cu(II) complexes with phosphines derived from fluoroquinolone against clinical and multidrug-resistant bacterial strains.
    Guz-Regner K; Komarnicka UK; Futoma-Kołoch B; Wernecki M; Cal M; Kozieł S; Ziółkowska A; Bugla-Płoskońska G
    J Inorg Biochem; 2020 Sep; 210():111124. PubMed ID: 32534287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of lipophilic fluoroquinolone derivatives.
    de Almeida CG; Diniz CG; Silva VL; Saraiva MF; Le Hyaric M; de Almeida MV
    Med Chem; 2009 Sep; 5(5):419-21. PubMed ID: 19534679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
    Fujimaki K; Noumi T; Saikawa I; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1988 Jun; 32(6):827-33. PubMed ID: 2843082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.
    Nguyen ST; Ding X; Butler MM; Tashjian TF; Peet NP; Bowlin TL
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5961-3. PubMed ID: 21865042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives.
    Chai Y; Liu ML; Lv K; Feng LS; Li SJ; Sun LY; Wang S; Guo HY
    Eur J Med Chem; 2011 Sep; 46(9):4267-73. PubMed ID: 21764484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities.
    Aziz HA; El-Saghier AMM; Badr M; Abuo-Rahma GEA; Shoman ME
    Mol Divers; 2022 Jun; 26(3):1743-1759. PubMed ID: 34455532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.